Prince Pharmaceutical Co., Ltd. (TPEX:6935)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
27.60
+0.10 (0.36%)
Mar 10, 2026, 11:20 AM CST
16.95%
Market Cap 1.01B
Revenue (ttm) 798.27M
Net Income (ttm) -10.94M
Shares Out 36.61M
EPS (ttm) -0.30
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 45,000
Average Volume 23,500
Open 27.85
Previous Close 27.50
Day's Range 27.50 - 27.85
52-Week Range 18.50 - 35.85
Beta 0.87
RSI 35.84
Earnings Date Mar 26, 2026

About Prince Pharmaceutical

Prince Pharmaceutical Co., Ltd. manufactures and sells vitamin B1 active pharmaceutical ingredients (APIs) in Taiwan, Japan, Korea, and internationally. The company also offers health food and medicines; vitamin c tablets, vitamin b complex tablets, natto and rhodiola extract capsules, probiotic sachets, and plant extract capsules; and API products comprising felbinac, aldioxa, tulobuterol, ufenamate, bisbentiamine, thiamine disulfide, potassium guaiacolsulfonate, potassium cresolsulfonate, fusultiamine hydrochloride, and fursultiamine. Prince ... [Read more]

Sector Healthcare
Founded 1962
Employees 210
Stock Exchange Taipei Exchange
Ticker Symbol 6935
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.